
ValueClick to buy Dotomi for $295M
ValueClick said Aug. 2 that it will pay $295 million to acquire Chicago-based online advertising firm Dotomi, the same day the Westlake Village-based firm announced earnings that beat analyst expectations.
Read More →
PCBC earns $21M in Q2
Pacific Capital Bancorp took another step toward getting out from under its regulatory consent order, reporting second-quarter net income of $21 million, or 64 cents per share, on July 27.
Read More →
Inphi shares take beating on lower profits
Wall Street punished Inphi Corp. on July 27, pushing down shares 20 percent after the company reported lower-than-expected earnings and gave a gloomier financial forecast than analysts had predicted.
Read More →
Beyond biologics: Amgen bets new drugs will pay dividend

Amgen executives believe the biotech giant will grow substantially in the next decade, pursuing drugs that treat major melanoma and bone loss.
Read More →